Gestión de heridas agudas y crónicas con apósitos de plata e inhibidores de metaloproteinasas
(Caso Herida aguda)
Wysocki, A.B., Staiano-Coico, L., Grinnel, F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101: 1, 64–68.
Bullen, E.C., Longaker, M.T., Updike, D.L. et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995; 104: 2, 236–240.
Nwomeh, B.C., Liang, H.X., Cohen, I.K., Yager, D.R. MMP-8 is the predominant collagenase in healing wounds and non-healing ulcers. J Surg Res1999; 81: 2, 189–195.
Wysocki, A.B., Kusakabe, A.O., Chang, S., Tuan, T.L. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen 1999; 7: 3, 154–165.
Tarlton, J.F., Bailey, A.J., Crawford, E. et al. Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen 1999; 7: 5, 347–355.
Rayment, E.A., Upton, Z., Shooter, G.K. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 2008; 158: 5, 951–961.
(Caso Herida crónica quemadura)
International Wound Institute (IWII) Wound infection in clinical practice. Wounds International 2016
Utz, E.R., Elster, E.A., Tadaki, D.K. et al. Metalloproteinase expression is associated with traumatic wound failure. J Surg Res 2010
Gillian S. Ashcroft, Michael A. Horan, Sarah E. Herrick, Roy W. Tarnuzzer, Gregory S. Schultz, Mark W.J. Ferguson. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell and Tissue Research. 1997